Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Chimerix Inc (NQ: CMRX )

0.9146 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Apr 15, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 0.9146
Bid (Size) 0.9200 (20)
Ask (Size) 0.9700 (20)
Prev. Close 0.9146
Today's Range 0.9146 - 0.9146
52wk Range 0.8800 - 1.450
Shares Outstanding 86,249,744
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Chimerix Appoints Marc D. Kozin to Board of Directors
Veteran Industry Executive Brings More Than 35 Years of Corporate Strategy Experience 
From Chimerix, Inc.
Via GlobeNewswire
Chimerix Reports Fourth Quarter and Year End 2023 Financial Results and Provides Operational Update
From Chimerix, Inc.
Via GlobeNewswire

Performance

YTD
-4.73%
-4.73%
1 Month
-16.85%
-16.85%
3 Month
-3.73%
-3.73%
6 Month
-9.45%
-9.45%
1 Year
-26.24%
-26.24%

More News

Read More
Earnings Scheduled For February 29, 2024
Via Benzinga
Preview: Chimerix's Earnings
Via Benzinga
Chimerix to Present at TD Cowen 44th Annual Health Care Conference
From Chimerix, Inc.
Via GlobeNewswire
Earnings Outlook For Chimerix
Via Benzinga
4 Analysts Have This to Say About Chimerix
Via Benzinga
Chimerix to Report Fourth Quarter and Year End 2023 Financial Results and Provide an Operational Update on February 29, 2024
From Chimerix, Inc.
Via GlobeNewswire
Chimerix Appoints Lisa Decker to Board of Directors
From Chimerix, Inc.
Via GlobeNewswire
Chimerix Promotes Michelle LaSpaluto to Chief Financial Officer
From Chimerix, Inc.
Via GlobeNewswire
Chimerix Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
From Chimerix, Inc.
Via GlobeNewswire
Chimerix Strengthens Executive Leadership Team with Appointment of Thomas Riga as Chief Operating and Commercial Officer
From Chimerix, Inc.
Via GlobeNewswire
Chimerix Reports Third Quarter 2023 Financial Results and Provides Operational Update
From Chimerix, Inc.
Via GlobeNewswire
Chimerix to Report Third Quarter 2023 Financial Results and Provide an Operational Update on November 2, 2023
From Chimerix, Inc.
Via GlobeNewswire
NetSol Technologies And 2 Other Stocks Under $2 Insiders Are Buying
Via Benzinga
Topics Stocks
Exposures US Equities
Overview Of Value Stocks In The Healthcare Sector
Via Benzinga
Chimerix to Participate in Upcoming Investor Conferences
From Chimerix, Inc.
Via GlobeNewswire
Chimerix Announces Data Highlighting Clinical Efficacy and Molecular Mechanisms of Response to ONC201 Treatment of H3 K27M-Mutant Diffuse Midline Gliomas Published in "Cancer Discovery"
From Chimerix, Inc.
Via GlobeNewswire
CMRX Stock Warning! Smart Biotech Investors Will Avoid Chimerix Like the Plague.
Via InvestorPlace
Chimerix Reports Second Quarter 2023 Financial Results and Provides Operational Update
From Chimerix, Inc.
Via GlobeNewswire
7 Millionaire-Maker Penny Stocks to Buy Before the Window Closes
Via InvestorPlace
Chimerix to Report Second Quarter 2023 Financial Results and Provide an Operational Update on August 3, 2023
From Chimerix, Inc.
Via GlobeNewswire
7 Small-Cap Stocks to Buy Before the Breakout
Via InvestorPlace
Why These 7 Stocks Are the Best Ways to Play Biotech Right Now
Via InvestorPlace
Chimerix Announces Promotion of Michael T. Andriole to President and Chief Executive Officer
From Chimerix, Inc.
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.